TEVA CANADA LIMITED — Irbesartan Importer Profile
Pharmaceutical Importer · #14 buyer for Irbesartan · $754.9K import value · 16 shipments · CANADA · DGFT Verified
TEVA CANADA LIMITED is the #14 importer of Irbesartan from India with $754.9K in import value and 16 verified shipments. TEVA CANADA LIMITED holds a 0.8% market share in Irbesartan imports based in CANADA. The company sources from 2 verified suppliers across 8 formulations shipped to 1 country.
TEVA CANADA LIMITED — Irbesartan Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Irbesartan to TEVA CANADA LIMITED?
Verified from 16 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TEVAPHARM INDIA PRIVATE LIMITED | $404.9K | 9 | 53.6% |
| MARKSANS PHARMA LIMITED | $350.0K | 7 | 46.4% |
TEVA CANADA LIMITED sources Irbesartan from 2 verified Indian suppliers based on 16 customs records. The primary supplier is TEVAPHARM INDIA PRIVATE LIMITED accounting for 53.6% of imports.
How Does TEVA CANADA LIMITED Compare to Nearest Irbesartan Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | CSP MYLAN SAS AT CSP- LABO 274, | FRANCE | $950.0K | 19 | $50.0K |
| 18 | CSP VIATRIS SANTE AT CSP- LAB | FRANCE | $950.0K | 19 | $50.0K |
| 14 | TEVA CANADA LIMITED ★ | CANADA | $800.0K | 16 | $50.0K |
| 3 | NEOETHICALS, S.A, | NICARAGUA | $600.0K | 12 | $50.0K |
TEVA CANADA LIMITED ranks #14 among 366 Irbesartan importers from India. Average shipment value of $50.0K compared to the market average of $68.3K. The closest competitors by value are CSP MYLAN SAS AT CSP- LABO 274, and CSP VIATRIS SANTE AT CSP- LAB.
Where Does TEVA CANADA LIMITED Import Irbesartan To?
Destination countries from 16 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $754.9K | 16 | 100.0% |
TEVA CANADA LIMITED imports Irbesartan to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $754.9K.
What Irbesartan Formulations Does TEVA CANADA LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| 172744, RATIO-IRBESARTAN 300 MG FT.FASS | $199.2K | 4 |
| PHARMACEUTICAL PRODUCTS -RATIO-IRBESARTAN 300MG FT.FASS F,VK,CA E BATCH NO:131518,131519,131514,131515,131516,131520,131NOS | $150.0K | 3 |
| 172731, RATIO-IRBESARTAN 150 MG FT.FASS | $139.1K | 3 |
| 172463, RATIO-IRBESARTAN 75 MG FT.FASS F | $66.6K | 2 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM -RATIO-IRBESARTAN 150M3 FT.FASS F,VK,CA E Batch No: 131086,131034, 131083, 131084,131085 Mfg Dt | $50.0K | 1 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM -RATIO-IRBESARTAN 300MG FT.FASS FVKCA E BATCH NO-131256131257131258131259131260 MFG DT:SEP | $50.0K | 1 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - RATIO-IRBESARTAN 150MG FT.FASS FVKCA E BATCH NO:131521131522 131523 MFG DT:NOV-2023 EXP D | $50.0K | 1 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - RATIO-IRBESARTAN 300MG FT.FASS FVKCA E BATCH NO:131492131493 MFG DT:OCT-2023 EXP DT:SEP-20 | $50.0K | 1 |
TEVA CANADA LIMITED imports 8 distinct Irbesartan formulations from India. The top formulation is 172744, RATIO-IRBESARTAN 300 MG FT.FASS with 4 shipments worth $199.2K.
Regulatory Requirements: Importing Irbesartan into Canada
What TEVA CANADA LIMITED and other importers must comply with to import Irbesartan from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Irbesartan
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Irbesartan from India and How Much Does TEVA CANADA LIMITED Import?
India exported $25.0M worth of Irbesartan through 2,669 shipments from 123 suppliers to 68 countries, serving 366 buyers globally. TEVA CANADA LIMITED imports $754.9K of this total, accounting for 0.8% of India's Irbesartan exports with 16 shipments from CANADA. This is verified from 16 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for TEVA CANADA LIMITED's Irbesartan Imports?
TEVA CANADA LIMITED's average Irbesartan order value is $47.2K per consignment, based on 16 shipments totaling $754.9K. TEVA CANADA LIMITED is based in CANADA and ranks #14 among all Irbesartan importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Irbesartan to TEVA CANADA LIMITED?
TEVA CANADA LIMITED sources Irbesartan from 2 verified Indian suppliers: TEVAPHARM INDIA PRIVATE LIMITED ($404.9K, 53.6%), MARKSANS PHARMA LIMITED ($350.0K, 46.4%). This is based on 16 customs records.
How Does TEVA CANADA LIMITED Compare to Other Irbesartan Importers?
TEVA CANADA LIMITED ranks #14 among 366 Irbesartan importers from India with a 0.8% market share. The top 3 importers are MACLEODS PHARMA USA INC ($3.7M), APOTEX PTY LTD. ($2.9M), YUSEN LOGISTICS BENELUX BELGIUM ($2.6M). TEVA CANADA LIMITED processed 16 shipments from CANADA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irbesartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TEVA CANADA LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TEVA CANADA LIMITED's capped import value divided by total capped export value for Irbesartan across all Indian exporters.
- 5.Verified Records: This page is backed by 16 individual customs records matching TEVA CANADA LIMITED importing Irbesartan, covering 8 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 68+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irbesartan Import Data for TEVA CANADA LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for TEVA CANADA LIMITED's Irbesartan imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TEVA CANADA LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
TEVA CANADA LIMITED × Irbesartan
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TEVA CANADA LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irbesartan. For current order-level data, contact TransData Nexus.